About Us

Our Vision

NanoBiotec Co. provides ultra-sensitive and reliable bioassay services to monitor real-time protein and gene changes in minimal samples from cell culture, animals, and patients to accelerate discovery and development of new therapeutics.

Our Mission

NanoBiotec is a privately held contract research organization (CRO) dedicated to increasing the efficiency of discovering and developing novel therapeutic drugs. We provide cost-effective services to the biopharma industry, and academic investigators to accelerate development of novel drugs and personalized medicine for cancer, inflammation, and many other unmet diseases.

Our mission is to provide maximal information from a minuscule amount of samples and thus accelerate the translation of high-caliber innovations to therapeutics as efficiently as possible to benefit our patients today, rather than in the future.

Our Platforms

We have established a unique infrastructure with cutting-edge technologies and state-of-the-art instruments. Our suite of advanced platforms enables highly sensitive bioanalysis and drug screening using minimal samples, allowing us to meet various desired assay performance requirements. Our passionate scientists have extensive hands-on experiences and training with these technologies and instruments and stringently follow highly standardized protocols to process and analyze samples quickly and accurately.

# Flow Cytometry (CytoFlex S with 4 lasers, 13 colors)

# Luminex® (beads-based Suspension Array)

# SIMOA® (SIngle MOlecule Array)

# Simple Western (Capillary-based Automatic Immunoblot)

# Proteomic Microarray Platform (Forward and Reverse Phase Protein Array)

# TaqMan® Low Density Array

# ABI QuantStudio Real-Time PCR

# Cellomics ArrayScan

# ECIS (Electric Cell-substrate Impedance Sensing)

# LiCor Odyssey Near-Infrared Imaging System

# ELISA / ELISpot Reader

# IncuCyte™ Live Cell Analysis System

# EVOS FL Auto Cell Imaging System

# Molecular Devices GenePix 4200AL Microarray Scanner

# Spark® Multimode Microplate Reader

# Integra ASSIST PLUS automated multichannel pipetting Robots

# Miltenyi Biotec autoMACS® Pro Separator

Our Team

Our team has unparalleled drug discovery, bio-analytical, cytometric, genomic and proteomic expertise, harnessing the power of ultrasensitive nanoscale & multiplex immunoassays and microarrays. Our employees have been trained at world-class institutes such as MIT, NIH, MSKCC, Rutgers, Mount Sinai Medical School and worked over decades for multinational biopharma companies, including Novartis, Sanofi, Merck, BMS, Celgene, Regeneron. We obtain and interpret the data from multiple experiments to evaluate drug efficacy and address the potential mechanism of drugs and diseases.

Partnering

Our strategy is focused on building R&D partnerships with biotech, pharmaceutical, and diagnostic companies, as well as government and academic institutions. NanoBiotec is eager to consider proposals for R&D collaboration, strategic partnerships, and co-marketing arrangements. For additional information, please email to info@NanoBiotecUsa.com.

NEWS

4) NanoBiotec is rated as one of the TOP PERFORMERS in 2018-2019. This was independently rated by fast-growing biotechs using Science Exchange, the world's leading R&D marketplace, based on RESPONSIVENESS, PRODUCTIVITY, POSITIVE CLIENT RECOMMENDATIONS. We are ranked as " #3 for various biomarker, functional and cell-based assays". (Science Exchange, Sept. 2019, Palo Alto, CA)

3) We are presenting in the Frontier in Cancer Immunotherapy, The New York Academy of Sciences, April 26, 2018, WTC, New York

We are presenting in the AACR 2017 Annual Meeting, April 16, 2017

2) We are presenting in the Mid-Atlantic LRIG: 22nd Annual Technology Showcase, May 11, 2016, Somerset, NJ

1) We are presenting in the AACR 2016 Annual Meeting, April 16, 2016, in New Orleans, LA

We are presenting in the Immunotherapy Biomarkers: Overcoming the Barriers, April 1, 2016, NIH, in Bethesda, MD

WHY WORK WITH US

Expertise in maximizing information from a minuscule amount of test samples; by harnessing the power of ultrasensitive nanoscale and multiplex immunoassays.
Better data acquisition and thus richer information from less animal use;
Faster turnaround, higher quality data, and more competitive prices;
Customized experiment design so that each project is catered to achieve its specific goal;
Careful safeguarding intellectual properties and fostering long-term relationships;
Confidence from each client, new and seasoned, giant and small, commercial and academic;
Greater flexibility for collaborations with academia and startups.

About Us

Our growing number of satisfied clients and partners

NanoBiotec Scientists proudly support many biopharma to obtain maximal data from miniscule samples.

We are the bridge from discovery to clinic, and scientists to patients.